Clinical Trials Directory

Trials / Completed

CompletedNCT03399461

Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS)

Understanding of the Patient and Caregiver Experience of Wiskott-Aldrich Syndrome (WAS)

Status
Completed
Phase
Study type
Observational
Enrollment
19 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
Male
Age
12 Years – 30 Years
Healthy volunteers
Not accepted

Summary

WAS is a rare primary immune deficiency disease caused by genetic mutation and is more common in males than females. The purpose of this study is to understand experiences of WAS subjects and caregivers to identify important concepts of interest that could be measured in future Phase IIIb trials. This is a qualitative cross-sectional study that will include a sample of approximately, 8 subjects with WAS and 13 caregivers of subjects with a diagnosis of WAS in the United States, United Kingdom and France. A 60 to 90 minute open-ended interview will be conducted over the telephone or video conference that will be audio-recorded for subsequent transcription. The aim of these interviews is to obtain subject and caregiver perspectives on the impact of WAS and its associated treatments on quality of life and experiences of living with WAS.

Conditions

Interventions

TypeNameDescription
OTHERPatient Interview guideThe interviewer will conduct the interview for subjects with WAS using a semi-structured patient interview guide.
OTHERCaregiver interview guideThe interviewer will conduct the interview for caregivers of subjects with WAS using a semi-structured caregiver interview guide.
OTHERSociodemographic questionnaireAt the end of interview, subjects will be required to complete subject or caregiver versions of country-specific sociodemographic questionnaire.
OTHERPediatric quality of life (PedsQL) questionnaireThe PedsQL is a validated generic measure of health-related quality of life (HRQOL) in children, adolescents, and young adults with acute and chronic health conditions. At the end of interview, subjects will be required to complete subject or caregiver versions of PedsQL questionnaire.
OTHERClinical questionnaireAt the end of interview, subjects will be required to complete subject or caregiver versions of clinical questionnaire.

Timeline

Start date
2018-01-24
Primary completion
2018-09-14
Completion
2018-09-14
First posted
2018-01-16
Last updated
2019-03-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03399461. Inclusion in this directory is not an endorsement.